With six high-profile papers published in the past seven months, biochemists in The Bridge@USC are poised to disrupt the future of pharmaceutical development and enable the advancement of personalized medicine.
With six high-profile papers published in the past seven months, biochemists in The Bridge@USC are poised to disrupt the future of pharmaceutical development and enable the advancement of personalized medicine.